Clinical Trial Update: A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and pharmacokinetics of AGS-8M4 in combination with chemotherapy in women with ovarian cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• AGS-8M4

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Carcinoma, Ovarian Cancer | Phase 1 | Status: TERMINATED